Previous 10 | Next 10 |
Health Catalyst Announces a New, External Leadership Assignment for Paul Horstmeier PR Newswire SALT LAKE CITY , Jan. 6, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services...
Tech stocks had as difficult a year as any sector in 2022, with the Nasdaq-100 tech index falling more than 39% over the past year. It's hard to find tech stocks , which are known for their growth, that weren't hit by falling share prices. Health Catalyst (NASDAQ: HCAT) ,...
Summary Health Catalyst, Inc., after a 74% downside, spells opportunity, especially when ratings are all favorable. However, analysts at Evercore think differently and have downgraded Health Catalyst stock. After assessing opportunities and risks, I conclude that Health Catalyst sto...
Health Catalyst ( NASDAQ: HCAT ), a vendor of software solutions to healthcare establishments, dropped Tuesday after Evercore ISI downgraded its shares to In-Line from Outperform, citing a challenging setup for health systems, including hospitals. “While it is not new that hosp...
Carle Health Partners with Health Catalyst to Achieve Data-Informed Improvement PR Newswire SALT LAKE CITY , Dec. 5, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to ...
Shares of Health Catalyst (NASDAQ: HCAT) , jumped 23.34% on Wednesday. The stock closed on Tuesday at $6.47, then opened on Wednesday at $8.54. It ran as high as $8.59 before closing at $7.98. So far this year, the stock is still down more than 79%. It has a 52-week low of $6.40 and...
Health Catalyst ( NASDAQ: HCAT ) stock rose ~23% on Wednesday after Q3 results beat estimates and the company raised its FY22 outlook which was seen above consensus. Total revenue grew +10.72% Y/Y to $68.35M. Technology revenue increased +15% Y/Y to ~$44M, wh...
Health Catalyst, Inc. (HCAT) Q3 2022 Earnings Conference Call November 08, 2022, 05:00 PM ET Company Participants Adam Brown - Senior Vice President-Finance and Investor Relations Daniel Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer ...
Health Catalyst press release ( NASDAQ: HCAT ): Q3 Non-GAAP EPS of -$0.13 beats by $0.06 . Revenue of $68.35M (+10.7% Y/Y) beats by $1.56M . Q4 revenue expected to be between $66.9 million and $68.9 million, vs. consensus of $66.79M. FY22 revenue between $2...
SALT LAKE CITY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2022. ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-01 07:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for HCAT on July 1, 2024 06:12AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-06-22 03:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...